MGRX
Mangoceuticals, Inc. Common Stock
NASDAQ: MGRX · HEALTHCARE · HEALTH INFORMATION SERVICES
$0.34
+2.56% today
Updated 2026-04-30
Market cap
$6.79M
P/E ratio
—
P/S ratio
14.88x
EPS (TTM)
$-2.17
Dividend yield
—
52W range
$0 – $3
Volume
15.5M
Mangoceuticals, Inc. Common Stock (MGRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $8939.00 | $731493.00 | $615873.00 | $456021.00 |
| Revenue growth (YoY) | — | — | +8083.2% | -15.8% | -26.0% |
| Cost of revenue | — | $4089.00 | $299992.00 | $235909.00 | $205635.00 |
| Gross profit | — | $4850.00 | $431501.00 | $379964.00 | $250386.00 |
| Gross margin | — | 54.3% | 59.0% | 61.7% | 54.9% |
| R&D | — | — | — | — | — |
| SG&A | $70080.00 | $1.64M | $3.32M | $6.42M | $15.90M |
| Operating income | $-17520.00 | $-1.99M | $-9.22M | $-7.97M | $-19.15M |
| Operating margin | — | -22279.7% | -1260.3% | -1294.4% | -4200.5% |
| EBITDA | $-17520.00 | $-1.99M | $-8.09M | $-7.96M | $-18.82M |
| EBITDA margin | — | -22236.5% | -1106.4% | -1292.8% | -4126.1% |
| EBIT | $-17520.00 | $-1.99M | $-8.12M | $-8.68M | $-20.54M |
| Interest expense | $181.00 | $6473.00 | $0.00 | $13700.00 | $103513.00 |
| Income tax | $-70080.00 | $-224622.00 | $1.00 | — | — |
| Effective tax rate | 79.8% | 10.1% | -0.0% | 0.0% | 0.0% |
| Net income | $-17701.00 | $-2.00M | $-9.21M | $-8.71M | $-20.64M |
| Net income growth (YoY) | — | -11187.8% | -361.1% | +5.5% | -137.1% |
| Profit margin | — | -22352.1% | -1259.4% | -1413.6% | -4526.9% |